Suppr超能文献

基因型和表型耐受性在治疗戈登链球菌所致实验性心内膜炎中的重要性。

Importance of genotypic and phenotypic tolerance in the treatment of experimental endocarditis due to Streptococcus gordonii.

作者信息

Entenza J M, Caldelari I, Glauser M P, Francioli P, Moreillon P

机构信息

Department of Internal Medicine, Centre Hospitalier Universitaire Vaudois, Lausanne, Switzerland.

出版信息

J Infect Dis. 1997 Jan;175(1):70-6. doi: 10.1093/infdis/175.1.70.

Abstract

Genotypic and phenotypic tolerance was studied in penicillin treatment of experimental endocarditis due to nontolerant and tolerant Streptococcus gordonii and to their backcross transformants. The organisms were matched for in vitro and in vivo growth rates. Rats with aortic endocarditis were treated for 3 or 5 days, starting 12, 24, or 48 h after inoculation. When started at 12 h, during fast intravegetation growth, 3 days of treatment cured 80% of the nontolerant parent compared with <30% of the tolerant derivative (P < .005). When started at 24 or 48 h and if intravegetation growth had reached a plateau, 3 days of treatment failed against both bacteria. However, a significant difference between the 2 organisms was restored when treatment was extended to 5 days. Thus, genotypic tolerance conferred a survival advantage in both fast- and slow-growing bacteria, demonstrating that the in vitro-defined tolerant phenotype also carried the risk of treatment failure in vivo.

摘要

在对由非耐受性和耐受性戈登链球菌及其回交转化体引起的实验性心内膜炎进行青霉素治疗时,研究了基因型和表型耐受性。这些生物体在体外和体内生长速率方面相互匹配。接种后12、24或48小时开始,对患有主动脉心内膜炎的大鼠进行3或5天的治疗。当在12小时开始治疗时,即在赘生物快速生长期间,3天的治疗使80%的非耐受性亲本治愈,而耐受性衍生物的治愈率<30%(P<.005)。当在24或48小时开始治疗且赘生物生长已达到平台期时,3天的治疗对两种细菌均无效。然而,当治疗延长至5天时,两种生物体之间的显著差异得以恢复。因此,基因型耐受性在快速生长和缓慢生长的细菌中均赋予了生存优势,表明体外定义的耐受性表型在体内也存在治疗失败的风险。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验